The forecast for Brazil's HIV-positive tuberculosis treatment success rate from 2024 to 2028 shows a stagnant pattern with a slight increase only in 2028. The rate remains steady at 50% from 2024 to 2027, with a minor uptick to 51% in 2028. In 2023, the success rate stood at 50%, indicating no significant year-on-year variation through 2027. Over this five-year period, the compound annual growth rate (CAGR) is negligible, showing minimal change in treatment outcomes.
Future trends to watch for include improvements in healthcare infrastructure and advancements in treatment protocols, which could enhance success rates. Monitoring policy changes and the integration of new medical technologies will be vital for shaping future outcomes.
